Literature DB >> 26497497

[Adjuvant radiotherapy significantly also reduces local recurrence rate for prognostically favorable DCIS].

René Pahl1, Jürgen Dunst2.   

Abstract

Mesh：

Year:  2015        PMID： 26497497     DOI： 10.1007/s00066-015-0906-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.

Authors:  J Boyages; G Delaney; R Taylor
Journal:  Cancer       Date:  1999-02-01       Impact factor: 6.860

2.  Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.

Authors:  Lawrence J Solin; Robert Gray; Lorie L Hughes; William C Wood; Mary Ann Lowen; Sunil S Badve; Frederick L Baehner; James N Ingle; Edith A Perez; Abram Recht; Joseph A Sparano; Nancy E Davidson
Journal:  J Clin Oncol       Date:  2015-09-14       Impact factor: 44.544

3.  Tamoxifen added to radiotherapy and surgery for the treatment of ductal carcinoma in situ of the breast: a meta-analysis of 2 randomized trials.

Authors:  Fausto Petrelli; Sandro Barni
Journal:  Radiother Oncol       Date:  2011-03-14       Impact factor: 6.280

4.  RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.

Authors:  Beryl McCormick; Kathryn Winter; Clifford Hudis; Henry Mark Kuerer; Eileen Rakovitch; Barbara L Smith; Nour Sneige; Jennifer Moughan; Amit Shah; Isabelle Germain; Alan C Hartford; Afshin Rashtian; Eleanor M Walker; Albert Yuen; Eric A Strom; Jeannette L Wilcox; Laura A Vallow; William Small; Anthony T Pu; Kevin Kerlin; Julia White
Journal:  J Clin Oncol       Date:  2015-01-20       Impact factor: 44.544

5.  Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial.

Authors:  Joan Houghton; W D George; Jack Cuzick; Catherine Duggan; Ian S Fentiman; Margaret Spittle
Journal:  Lancet       Date:  2003-07-12       Impact factor: 79.321

Review 6.  Postoperative tamoxifen for ductal carcinoma in situ.

Authors:  Helen Staley; Iain McCallum; Julie Bruce
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17

7.  Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.

Authors:  Lorie L Hughes; Molin Wang; David L Page; Robert Gray; Lawrence J Solin; Nancy E Davidson; Mary Ann Lowen; James N Ingle; Abram Recht; William C Wood
Journal:  J Clin Oncol       Date:  2009-10-13       Impact factor: 44.544

8.  Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.

Authors:  Jack Cuzick; Ivana Sestak; Sarah E Pinder; Ian O Ellis; Sharon Forsyth; Nigel J Bundred; John F Forbes; Hugh Bishop; Ian S Fentiman; William D George
Journal:  Lancet Oncol       Date:  2010-12-07       Impact factor: 41.316
  8 in total
  2 in total

1.  [Omission of adjuvant radiotherapy in ductal carcinoma in situ : 12 year-results of the ECOG-ACRIN E5194-trial].

Authors:  David Krug; Rainer Souchon
Journal:  Strahlenther Onkol       Date:  2016-05       Impact factor: 3.621

Review 2.  Current controversies in radiotherapy for breast cancer.

Authors:  David Krug; René Baumann; Wilfried Budach; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Marc D Piroth; Marie-Luise Sautter-Bihl; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Radiat Oncol       Date:  2017-01-23       Impact factor: 3.481
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.